Human epidermal growth factor receptor 2 (HER-2)-positive breast cancer comprises 20%–30% breast cancers caused by an abnormality of the HER-2 gene on the 17th chromosome, resulting in amplification and overexpression of the cancer cell surface field [1]. Here, ERBB2 is linked to breast carcinoma.